The potential use of adult stem cells for the treatment of multiple sclerosis and other neurodegenerative disorders

Clinical Neurology and Neurosurgery

Volumn 110, Issue 9, 2008, Pages 943-946

  Slavin, Shimon ^a   Kurkalli, Basan G S ^a   Karussis, Dimitrios ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Central nervous system (CNS); Experimental autoimmune encephalomyelitis (EAE); Immunomodulation; Mesenchymal stromal cells (MSC); Multiple sclerosis (MS); Neurodegeneration; Neurological repair; Stem cells

Indexed keywords

ADULT STEM CELL; ARTICLE; CELL MIGRATION; DEGENERATIVE DISEASE; GLIA CELL; IMMUNOMODULATION; INFLAMMATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPLE SCLEROSIS; NERVE CELL; NEUROPROTECTION;

ADULT STEM CELLS; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; CLINICAL TRIALS AS TOPIC; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; INJECTIONS, SPINAL; MICE; MULTIPLE SCLEROSIS; NEURODEGENERATIVE DISEASES; PILOT PROJECTS;

EID: 53349128309     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2008.01.014     Document Type: Article

References (41)

1. Karussis D., Grigoriadis S., Polyzoidou E., Grigoriadis N., Slavin S., and Abramsky O. Neuroprotection in multiple sclerosis. Clin Neurol Neurosurg 108 3 (2006) 250-254 [Epub 2006 Jan 4. Review]
2. Steinman L. Multiple sclerosis: a two-stage disease. Nat Immunol 9 (2001) 762-764
3. Slavin S. Successful treatment of autoimmune disease in (NZB/NZW)F1 female mice by using fractionated total lymphoid irradiation. Proc Natl Acad Sci USA 76 (1979) 5274-5276
4. Slavin S. Treatment of life threatening autoimmune diseases with myeloablative doses of immunosuppressive agents and autologous bone marrow transplantation-rationale and experimental background. BMT 12 (1993) 85-88
5. Karussis D.M., Slavin S., Ben-Nun A., Ovadia H., Vourka-Karussis U., Lehmann D., et al. Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation. J Neuroimmunol 39 (1992) 201-210
6. Slavin S., Karussis D., Weiss L., Vourka-Karussis U., and Abramsky O. Immunohematopoietic reconstitution by allogeneic and autologous bone marrow grafts as a means for induction of specific unresponsiveness to donor-specific allografts and modified self in autoimmune disorders. Transplant Proc 25 (1993) 1274-1275
7. Karussis D.M., Vourka-Karussis U., Lehmann D., Abramsky O., Ben-Nun A., and Slavin S. Successful treatment of autoimmunity in MRL/lpr mice with T-cell depleted syngeneic bone marrow transplantation. EOS J Immunol Immunopharm XIII (1993) 78-79
8. Slavin S. Autologous and allogeneic stem cell transplantation for the treatment of autoimmune diseases as a potential new approach. In: Shoenfeld Y. (Ed). The Decade of Autoimmunity (1999), Elsevier 399-408
9. Slavin S., and Nagler A. Bone marrow transplantation for cancer and autoimmunity. In: Shoenfeld Y., and Gershwin E. (Eds). Cancer and Autoimmunity (2000), Elsevier 409-421
10. Burt R.K., Slavin S., Burns W.H., and Marmont A.M. Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?. Blood 99 3 (2001) 768-784
11. Burt K.R., Verda L., Oyama Y., Statkute L., and Slavin S. Non-myeloablative stem cell transplantation for autoimmune diseases. Springer Semin Immun 26 (2004) 57-69
12. Slavin S., Marmont A., and Burt R. Allogeneic hematopoietic stem cell transplantation for autoimmune disease. In: Slavin S., Marmont A., and Burt R. (Eds). Stem Cell therapy for Autoimmune Disease (2004), Landes Bioscience, Texas, USA 474-478
13. Burt R., Cohen B., Rose J., Petersen F., Oyama Y., Stefoski D., et al. Hematopoietic stem cell transplantation for multiple sclerosis. Arch Neurol 62 6 (2005) 860-864
14. van Laar J.M., and Tyndall A. Adult stem cells in the treatment of autoimmune diseases. Rheumatology (Oxford) 45 10 (2006) 1187-1193
15. Dazzi F., van Laar J.M., Cope A., and Tyndall A. Cell therapy for autoimmune diseases. Arthritis Res Ther 9 2 (2007) 206
16. Conget P.A., and Minguell J.J. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 181 1 (1999) 67-73
17. Meirelles Lda S., and Nardi N.B. Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization. Br J Haematol 123 4 (2003) 702-711
18. Karussis D.M., Grigoriadis N., Ben-Hur T., Gouda-Kurkalli B., Mizrachi-Koll R., Einstein O., et al. Mesenchymal bone marrow stem cells, migrate into CNS lesions in experimental autoimmune encephalomyelitis, differentiate into neuronal and glial line and downregulate chronic EAE. Neurology 64 6 (2005)
19. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276 5309 (1997) 71-74
20. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 5411 (1999) 143-147
21. Cao Q., Benton R.L., and Whittemore S.R. Stem cell repair of central nervous system injury. J Neurosci Res 68 5 (2002) 501-510
22. Krampera M., Glennie S., Dyson J., Scott D., Laylor R., Simpson E., et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 101 9 (2003) 3722-3729
23. Le Blanc K., Tammik L., Sundberg B., Haynesworth S.E., and Ringden O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57 1 (2003) 11-20
24. Beyth S., Borovsky Z., Mevorach D., Liebergall M., Gazit Z., Aslan H., et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105 5 (2005) 2214-2219
25. Augello A., Tasso R., Negrini S.M., Amateis A., Indiveri F., Cancedda R., et al. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol 35 5 (2005) 1482-1490
26. Deng W., Han Q., Liao L., You S., Deng H., and Zhao R.C. Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice. DNA Cell Biol 24 7 (2005) 458-463
27. Sotiropoulou P.A., Perez S.A., Gritzapis A.D., Baxevanis C.N., and Papamichail M. Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells 24 1 (2006) 74-85
28. Spaggiari G.M., Capobianco A., Becchetti S., Mingari M.C., and Moretta L. Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood 107 4 (2006) 1484-1490
29. Tyndall A., Walker U.A., Cope A., Dazzi F., De Bari C., Fibbe W., et al. Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005. Arthritis Res Ther 9 1 (2007) 301 Review
30. Sanchez-Ramos J., Song S., Cardozo-Pelaez F., Hazzi C., Stedeford T., Willing A., et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 164 2 (2000) 247-256
31. Woodbury D., Schwarz E.J., Prockop D.J., and Black I.B. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61 4 (2000) 364-370
32. Bossolasco P., Cova L., Calzarossa C., Rimoldi S.G., Borsotti C., Deliliers G.L., et al. Neuro-glial differentiation of human bone marrow stem cells in vitro. Exp Neurol 193 2 (2005) 312-325
33. Mahmood A., Lu D., Wang L., and Chopp M. Intracerebral transplantation of marrow stromal cells cultured with neurotrophic factors promotes functional recovery in adult rats subjected to traumatic brain injury. J Neurotrauma 19 12 (2002) 1609-1617
34. Dezawa M., Kanno H., Hoshino M., Cho H., Matsumoto N., Itokazu Y., et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest 113 12 (2004) 1701-1710
35. Zappia E., Casazza S., Pedemonte E., Benvenuto F., Bonanni I., Gerdoni E., et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106 5 (2005) 1755-1761
36. Orlic D. Adult bone marrow stem cells regenerate myocardium in ischemic heart disease. Ann NY Acad Sci 996 (2003) 152-157
37. Couri C.E., Foss M.C., and Voltarelli J.C. Secondary prevention of type 1 diabetes mellitus: stopping immune destruction and promoting beta-cell regeneration. Braz J Med Biol Res 39 10 (2006) 1271-1280
38. Watorek E., and Klinger M. Stem cells in nephrology: present status and future. Arch Immunol Ther Exp (Warsz) 54 1 (2006) 45-50
39. Siepe M., Heilmann C., von Samson P., Menasche P., and Beyersdorf F. Stem cell research and cell transplantation for myocardial regeneration. Eur J Cardiothorac Surg 28 2 (2005) 318-324
40. Karussis D., and Kassis I. Use of stem cells for the treatment of multiple sclerosis. Expert Rev Neurother 9 (2007) 1189-1201
41. Karussis D., Grigoriadis S., Polyzoidou E., Grigoriadis N., Slavin S., and Abramsky O. Neuroprotection in multiple sclerosis. Clin Neurol Neurosurg 108 3 (2006) 250-254 [Epub Jan 4, 2006]